Hisun Pharmaceuticals USA Inc.

HISUN USA is a pharmaceutical company dedicated to acquiring, developing, and commercializing novel pharmaceutical and biotechnology products for the US, China, and global markets. The company offers an extensive portfolio of active pharmaceutical ingredients (API) with over 130 products sold to more than 60 countries. They also focus on creating a broad portfolio of generic drug products by leveraging the diverse capabilities of their parent company and strategically acquiring products and technologies in the US market. HISUN USA operates a globally integrated network of four manufacturing facilities, built to produce and deliver a wide range of finished products internationally. Their services include API service for nutritional products, drug product service, and biological service, catering to various pharmaceutical needs.